Shopping Cart
- Remove All
Your shopping cart is currently empty
A2AR/A2BR antagonist 1 (compound 7ai) acts as a dual antagonist to A2AR and A2BR with IC50 values of 11.2 nM and 6.4 nM, respectively. Additionally, A2AR/A2BR antagonist 1 enhances T cell-mediated cancer cell death.

| Description | A2AR/A2BR antagonist 1 (compound 7ai) acts as a dual antagonist to A2AR and A2BR with IC50 values of 11.2 nM and 6.4 nM, respectively. Additionally, A2AR/A2BR antagonist 1 enhances T cell-mediated cancer cell death. |
| Targets&IC50 | A2BR:6.4 nM, A2AR:11.2 nM |
| In vitro | The compound 2A R/A 2B R antagonist 1 (compound 7ai) at concentrations of 0.1, 1, and 10 μM over 0-48 hours can reverse NECA-induced immunosuppression, thereby enhancing OT-I CTL cell activation and cytotoxicity, leading to antitumor activity. |
| Formula | C24H17N9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.